Bioventus Inc.
BVS
$8.21
-$0.94-10.27%
| 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 78.53% | 78.31% | 75.99% | 87.86% | -209.62% |
| Total Depreciation and Amortization | -28.66% | -47.63% | -8.70% | 8.64% | 63.74% |
| Total Amortization of Deferred Charges | -16.67% | 50.46% | 50.46% | 50.46% | 50.46% |
| Total Other Non-Cash Items | -57.94% | -65.54% | -66.54% | -82.47% | 1,088.87% |
| Change in Net Operating Assets | -270.32% | -390.78% | -224.35% | -247.01% | -164.75% |
| Cash from Operations | 152.83% | 192.22% | -37.09% | -31.32% | 213.35% |
| Capital Expenditure | 86.34% | 92.30% | 66.83% | 54.49% | 12.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -28.83% | -100.64% | -100.64% | -- | -- |
| Other Investing Activities | 93.84% | 93.84% | 93.84% | 98.85% | 77.65% |
| Cash from Investing | 45.27% | -113.33% | 91.03% | 123.55% | 113.58% |
| Total Debt Issued | -- | -100.00% | -69.39% | -74.58% | 156.00% |
| Total Debt Repaid | 31.72% | 87.93% | 78.89% | -126.69% | -461.94% |
| Issuance of Common Stock | 213.88% | -12.10% | 2.68% | -73.95% | -85.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 161.48% | 52.17% | 50.68% | -121.54% | -11,162.16% |
| Cash from Financing | -104.78% | 63.40% | -137.42% | -172.62% | -142.94% |
| Foreign Exchange rate Adjustments | -507.00% | -109.82% | -159.04% | -129.12% | -17.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.93% | 315.05% | 122.43% | 38.32% | 107.61% |
